Evidence map›Paper›PMID 19036940›Full record

ReviewAmerican journal of physiology. Cell physiology2009

Muscarinic receptors and ligands in cancer.

Nirish Shah, Sandeep Khurana, Kunrong Cheng, Jean-Pierre Raufman

Abstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Cholinergic Mechanisms in Gastrointestinal Neoplasia.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. GPCRs and fibroblast heterogeneity in fibroblast-associated diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nirish ShahDivision of Gastroenterology and Hepatology, Univ. of Maryland School of Medicine, 22 South Greene St., N3W62, Baltimore, MD 21201, USA.
Sandeep Khurana
Kunrong Cheng
Jean-Pierre Raufman
University of Maryland, Baltimore · USUniversity Gastroenterology · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
Role of M3 muscarinic receptors in bile acid-induced colon cancerR01CA120407 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2008 to 2011
$1.2M
Bile acid-induced colon cancer cell proliferationR01CA107345 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2009
$1.1M
Mechanisms of Vascular Dysfunction in CirrhosisK08DK081479 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI KHURANA, SANDEEP · 2008 to 2012
$716k
NCI NIH HHS CA-107345NCI NIH HHS CA-120407NIDDK NIH HHS K08 DK081479NIDDK NIH HHS K08-DK-081479NIDDK NIH HHS T32 DK067872NIDDK NIH HHS T32-DK-067872
6 · The paper itself

Abstract

Emerging evidence indicates that muscarinic receptors and ligands play key roles in regulating cellular proliferation and cancer progression. Both neuronal and nonneuronal acetylcholine production results in neurocrine, paracrine, and autocrine promotion of cell proliferation, apoptosis, migration, and other features critical for cancer cell survival and spread. The present review comprises a focused critical analysis of evidence supporting the role of muscarinic receptors and ligands in cancer. Criteria are proposed to validate the biological importance of muscarinic receptor expression, activation, and postreceptor signaling. Likewise, criteria are proposed to validate the role of nonneuronal acetylcholine production in cancer. Dissecting cellular mechanisms necessary for muscarinic receptor activation as well as those needed for acetylcholine production and release will identify multiple novel targets for cancer therapy.

Indexed as

Signal TransductionAcetylcholineAnimalsAntineoplastic AgentsApoptosisCell MovementCell ProliferationDisease ProgressionHumansLigandsMuscarinic AntagonistsNeoplasmsNeuronsProtein ConformationReceptors, MuscarinicAcetylcholineAntineoplastic AgentsLigandsMuscarinic AntagonistsReceptors, Muscarinic

Identifiers

PMID19036940
PMCPMC2643856
OpenAlexW2006126215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.